I believe it’s a mix. I was an early poster on this discussion. I had Pfizer. If you go through the discussion you can get a sense of the numbers for each vaccine.

Hello, I just looked again at the VAERS data for your answer.
Based on reporting of neuropathies of all types in VAERS, and the number of vaccine doses given so far it appears that the mRNA vaccines are safer with a report of about 3.1-3.4 cases of neuropathy per million injections while Johnson & Johnson reports about 12 cases per million injections (even assuming vast underreporting, that's very rare).

By contrast, about 10% - 20% of hospitalized Covid patients experience neuropathy, with those who have a prior history more likely to have symptoms. 2,380,000 people have been hospitalized of 34,700,000 infected, resulting in somewhere between 200,000 - 450,000 cases of neuropathy.

I did the math - chances of this complication, as an unvaccinated person, is 75-150 chances in a million. That is at least 20 to 40 times higher than getting the vaccine. (11% chance of getting Covid, times a 7% chance of hospitalization times a 10-20% chance of new worse neuropathy)

Keep in mind there are dozens of other potential long-term effects from Covid as well, and those increase and worsen with every health condition you have. And the Delta variant is ramping up, sending more and younger people to the hospital, and we have no idea what those long-term effects will be yet.

Does any of this help with making your decision?

Hi. Personally I have been waiting for approval of a traditional vaccine. NovaVAX phase 3 clinical trial results came out at the end of June. Dr Mobeen Syed Analyzed the results in a YouTube video which was very informative. Here is the trial data From new England journal of medicine
https://www.nejm.org/doi/full/10.1056/NEJMoa2107659